0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Colon Cancer Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Capecitabine Market by Indication, Distribution Channel, End User, Dosage Strength, Formulation, Therapy Regimen, Packaging - Global Forecast to 2030 - Product Thumbnail Image

Capecitabine Market by Indication, Distribution Channel, End User, Dosage Strength, Formulation, Therapy Regimen, Packaging - Global Forecast to 2030

  • Report
  • May 2025
  • 192 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Colorectal Cancer Drugs Market by Drug Class, Distribution Channel, Route Of Administration, Line Of Therapy, Target Molecule, Treatment Setting - Global Forecast to 2030 - Product Thumbnail Image

Colorectal Cancer Drugs Market by Drug Class, Distribution Channel, Route Of Administration, Line Of Therapy, Target Molecule, Treatment Setting - Global Forecast to 2030

  • Report
  • May 2025
  • 198 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Familial Adenomatous Polyposis Treatment Market by Drug Class, Therapy Line, Route of Administration, Distribution Channel, End User - Global Forecast to 2030 - Product Thumbnail Image

Familial Adenomatous Polyposis Treatment Market by Drug Class, Therapy Line, Route of Administration, Distribution Channel, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 197 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Anal Cancer Market by Treatment Type, End User, Therapeutic Line, Disease Stage, Administration Mode, Cancer Type, Distribution Channel - Global Forecast to 2030 - Product Thumbnail Image

Anal Cancer Market by Treatment Type, End User, Therapeutic Line, Disease Stage, Administration Mode, Cancer Type, Distribution Channel - Global Forecast to 2030

  • Report
  • May 2025
  • 182 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Colorectal Cancer Screening & Diagnostic Market by Type, Product, Application, End User - Global Forecast to 2030 - Product Thumbnail Image

Colorectal Cancer Screening & Diagnostic Market by Type, Product, Application, End User - Global Forecast to 2030

  • Report
  • May 2025
  • 186 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Metastatic Colorectal Cancer Market: Focus on Drug Class, and Region - Analysis and Forecast, 2025-2035 - Product Thumbnail Image

Metastatic Colorectal Cancer Market: Focus on Drug Class, and Region - Analysis and Forecast, 2025-2035

  • Report
  • May 2025
  • 100 Pages
  • Global
From
EUR$4,900USDGBP
Betaferon or Betaseron Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Thumbnail Image

Betaferon or Betaseron Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • April 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Vectibix (panitumumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Thumbnail Image

Vectibix (panitumumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • April 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Erbitux Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Thumbnail Image

Erbitux Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • April 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Cyramza (Ramucirumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Thumbnail Image

Cyramza (Ramucirumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • April 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Avastin (Bevacizumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Thumbnail Image

Avastin (Bevacizumab) Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • April 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Bevacizumab Biosimilars Market Report 2025 - Product Thumbnail Image

Bevacizumab Biosimilars Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Gardner Syndrome Treatment Market Report 2025 - Product Thumbnail Image

Gardner Syndrome Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Colorectal Cancer Drugs Market Report 2025 - Product Thumbnail Image

Colorectal Cancer Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Capecitabine Market Report 2025 - Product Thumbnail Image

Capecitabine Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
EUR$4,490USDGBP
Metastatic Colorectal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Metastatic Colorectal Cancer Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
EUR$3,250USDGBP
EUR$4,850USDGBP
Colorectal Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Colorectal Cancer Therapeutics - Global Strategic Business Report

  • Report
  • June 2025
  • 363 Pages
  • Global
From
EUR$5,850USDGBP
Capecitabine - Global Strategic Business Report - Product Thumbnail Image

Capecitabine - Global Strategic Business Report

  • Report
  • June 2025
  • 220 Pages
  • Global
From
EUR$5,850USDGBP
Methotrexate Drugs - Global Strategic Business Report - Product Thumbnail Image

Methotrexate Drugs - Global Strategic Business Report

  • Report
  • June 2025
  • 564 Pages
  • Global
From
EUR$5,850USDGBP
Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Thumbnail Image

Colorectal Cancer Screening and Diagnostic Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • April 2025
  • 183 Pages
  • Global
From
EUR$3,825USDGBP
EUR$4,500USDGBP
Loading Indicator

The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy. Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells. Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more